System Maintenance Announcement Several AANP systems will be undergoing maintenance and updates on 6/3/23 (Saturday) and 6/4/23 (Sunday). During this maintenance window, users of the CE Center and other AANP services may experience intermittent connection issues or an inability to connect. Full function of all system services should resume by 6 PM CT on 6/4 (if not sooner). Please plan your activities for these two days accordingly.
There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Adding Registration, Please wait...
You must be logged in to perform this action.
Log in
Cancel
Dual Antiplatelet Therapy: Guidance for Nurse Practitioners
JNP Article for September 2022
Credit(s):
1 Contact Hour(s) of CE; all of which may be applied towards Pharmacology
Released: September 1, 2022 Expires: September 30, 2023 (subject to change)
CE for this activity will not be available after this date.
Registration for this activity is only available to AANP Members.
Overview The aim of this review is to support primary care NPs in the outpatient setting, who must determine the length of Dual antiplatelet therapy (DAPT) as part of a long-term post-ACS care strategy. Current guideline recommendations regarding the choice of P2Y12 inhibitor and duration of DAPT in patients with ACS are reviewed.
This CE article is in The Journal for Nurse Practitioners (JNP) September 2022 issue.CE Credit Instructions Read this activity description, including objectives and disclosures.
Complete the educational content completely:
Articles: Read articles/monographs fully.
Review all additional materials provided (handouts, posttest reviews, other downloadable resources).
After completing all content, go to Steps to Receive Credit to complete the posttest and evaluation to receive full AANP CE/Rx credit. If other types of credit are offered, these options will be available after completing the activity evaluation.Objectives: At the completion of this activity the participant will be able to:
Choose patients who should be treated with DAPT.
Evaluate the risks and benefits of treatment with DAPT.
Articulate the role of the nurse practitioner in caring for patients who are being treated with DAPT
Authors: Suzanne O’Keefe, DNP, CRNP Shannon Idzik, DNP, ANP-BC, FAANP, FAANDisclosure This program was planned in accordance with AANP CE Standards and Policies. The authors have no relevant affiliations to disclose.
This educational activity may contain opinions of the authors from their personal experience. The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.Additional Information For questions or more information concerning this online CE opportunity contact the AANP CE Center Manager at CECenter@aanp.org.
1 Contact Hour(s) of CE, All of which may be applied towards Pharmacology
Purchase Options
Not seeing a REGISTER button here? This activity may only be available to AANP members or may be an informational page. Please read the activity description tab for more information.
Adding Registration, Please wait...
